Fed. Circ. Wipes Out Medicines Co.'s Angiomax Patents
The Federal Circuit on Thursday invalidated two of The Medicines Co.'s patents for the blood thinning drug Angiomax, finding that the claimed process was offered for sale before the patent applications...To view the full article, register now.
Already a subscriber? Click here to view full article